Association between transforming growth factor-β1 polymorphisms and hepatocellular cancer risk: A meta-analysis

Hepatology Research

Volumn 42, Issue 6, 2012, Pages 583-590

  Xiang, Tian Xin ^a   Cheng, Na ^a   Li, Xi Nv ^a   Wu, Xiao Ping ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Hepatocellular cancer; Meta analysis; Polymorphism; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC ASSOCIATION; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84860672829     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00958.x     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Michielsen PP, Francque SM, van Dongen JL. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 2005; 3: 27.
3. Liu GY, Jiang DK, Shen SQ, Yu L. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis. Arch Med Res 2011; 42: 149-55.
4. Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008; 48: 2047-63.
5. Apte RN, Dotan S, Elkabets M etal. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 2006; 25: 387-408.
6. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 2003; 37: 493-503.
7. Chang SJ, Chen CJ, Tsai FC etal. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene. Rheumatology (Oxford) 2008; 47: 617-21.
8. Yuan X, Liao Z, Liu Z etal. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 2009; 27: 3370-8.
9. Grainger DJ, Heathcote K, Chiano M etal. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93-7.
10. Qi X, Ma X, Yang X etal. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16, 480 cases and 22, 388 controls. Breast Cancer Res Treat 2010; 123: 499-506.
11. Kim YJ, Lee HS, Im JP etal. Association of transforming growth factor-(beta)1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003; 35: 196-202.
12. Kwon OS, Song SH, Ju KT etal. Polymorphism in codons 10 and 25 of the transforming growth factor-beta1 gene in Korean population and in patients with liver cirrhosis and hepatocellular carcinoma. Korean J Gastroenterol 2003; 42: 212-19.
13. Migita K, Miyazoe S, Maeda Y etal. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection - association between TGF-(beta)1 polymorphisms and hepatocellular carcinoma. J Hepatol 2005; 42: 505-10.
14. Falleti E, Fabris C, Toniutto P etal. TGF-(beta)1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. Cytokine 2008; 44: 256-61.
15. Zhang ZJ. Association between gene polymorphisms of TGF beta 1 and the susceptibility to primary hepatic carcinoma. China South University. 2008 (article in Chinese).
16. Okamoto K, Ishida C, Ikebuchi Y etal. The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. Intern Med 2010; 49: 887-95.
17. Qi P, Chen YM, Wang H etal. -509C>T polymorphism in the TGF-(beta)1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection. Cancer Immun 2009; 58: 1433-40.
18. Qin JN. Exploration on the relation between genetic polymorphisms in TGF beta signaling pathway and hepatocellular carcinoma and nasopharyngeal. Guangxi Medical University. 2009 (article in Chinese).
19. Yang Y. The genetic polymorphism of cytokine genes in Guangxi and hepatocellular carcinoma susceptibility. Guangxi Medical University. 2011 (article in Chinese).
20. Acun T, Terzioglu-Kara E, Konu O, Ozturk M, Yakicier MC. Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma. Mutat Res 2010; 684: 106-8.
21. Rosfjord EC, Dickson RB. Growth factors, apoptosis, and survival of mammary epithelial cells. J Mammary Gland Biol Neoplasia 1999; 4: 229-37.
22. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-8.
23. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137-61.
24. Haukim N, Bidwell JL, Smith AJ etal. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 2002; 3: 313-30.
25. Fang F, Yu L, Zhong Y, Yao L. TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis. Med Oncol 2010; 27: 1324-8.
26. Huang Y, Hao Y, Li B etal. Lack of significant association between TGF-beta1-590C/T polymorphism and breast cancer risk: a meta-analysis. Med Oncol 2011; 28: 424-8.
27. Woo SU, Park KH, Woo OH etal. Association of a TGF-beta1 gene -509 C/T polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010; 124: 481-5.
28. Qi X, Zhang F, Yang X etal. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies. Breast Cancer Res Treat 2010; 122: 273-9.
29. Guo J, Meng H, Pei J, Zhu M. Association between the TNF-alpha-238G>A and TGF-beta1 L10P polymorphisms and breast cancer risk: a meta-analysis. Breast Care (Basel) 2011; 6: 126-9.
30. Huang Y, Li B, Qian J, Xie J, Yu L. TGF-beta1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25, 996 subjects. Breast Cancer Res Treat 2010; 123: 863-8.
31. Gu D, Zhuang L, Huang H etal. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10, 417 cases and 11, 455 controls. Breast Cancer Res Treat 2010; 123: 857-61.
32. Wei BB, Xi B, Wang R etal. TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies. Cancer Genet Cytogenet 2010; 196: 68-75.
33. Qiu LX, Yao L, Mao C etal. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47, 817 subjects. Breast Cancer Res Treat 2010; 123: 563-7.